The novel therapy of this peptide represents a major advance in the handling of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – resulting https://tirzepatidepeptide306260.ja-blog.com/42334514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment